Harnessing AI and Data to Transform Clinical Trials

Now in its second year, SCOPE X: AI Innovation in Clinical Research delivers the next layer of innovation in clinical research as artificial intelligence moves from experimentation toward real-world implementation. Part of the trusted SCOPE series, SCOPE X is created for clinical research executives and thought leaders who want to move beyond surface-level discussions and explore how AI is transforming clinical trials in practice.

Taking place May 17–18, 2027, at the Hynes Convention Center in Boston and online, SCOPE X brings together clinical research leaders, clinical operations executives, heads of clinical transformation and AI, technology innovators, AI start-ups, and subject-matter experts for focused conversations on solving the industry’s most pressing challenges.

Following a highly successful inaugural event, SCOPE X returns with three programs:

• AI across the Clinical Trial Lifecycle
• Agent Validation, Trust, Governance & Economics
• AI for Smarter Trials

Expect interactive short courses, engaging sessions, detailed case studies, and collaborative problem-solving designed to generate ideas you can put into practice at your organization. With a community-driven program and collaborative setting, SCOPE X offers two days of in-depth exchange, meaningful discussion, and high-value networking for those serious about harnessing AI to make clinical trials smarter, faster, and more effective.

Key Areas of Focus

• AI for clinical trial design, operations, and delivery
• Scaling AI adoption, managing costs, and demonstrating value
• Building trust through validation, governance, and human oversight
• AI agents, agentic AI, and AI teammates transforming clinical workflows
• Predictive intelligence, modeling, forecasting, and decision-making